Gecacitinib to Treat Low-Risk Myelodysplastic Syndrome (MDS) with Anemia

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
This article has no abstract
Epistemonikos ID: e0b84d9cd6b4768c7d476e67ec4f712bdd1a8d0a
First added on: Sep 12, 2026